Table I.
CD3+ | CD11b+ | CD45+ | CD14+ | |
---|---|---|---|---|
Average | 0.00 | 69.9 | 86.8 | 40.0 |
SD | 0.00 | 15.7 | 11.6 | 19.2 |
Samples of 17 DUOC-01 manufacturing runs were analyzed by means of multiparameter flow cytometry as described in Figure 2; n = 17.
CD3+ | CD11b+ | CD45+ | CD14+ | |
---|---|---|---|---|
Average | 0.00 | 69.9 | 86.8 | 40.0 |
SD | 0.00 | 15.7 | 11.6 | 19.2 |
Samples of 17 DUOC-01 manufacturing runs were analyzed by means of multiparameter flow cytometry as described in Figure 2; n = 17.